دورية أكاديمية

Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer

التفاصيل البيبلوغرافية
العنوان: Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer
المؤلفون: Bernhard Tribukait
المصدر: Cancers, Vol 13, Iss 21, p 5442 (2021)
بيانات النشر: MDPI AG, 2021.
سنة النشر: 2021
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: circulating thymidine kinase 1, cell loss, biomarker, early treatment response, breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Pathologic complete response (pCR) predicts the long-term outcome of neoadjuvantly treated (NAC) breast cancer (BC) but is reached in p = 0.005), and DFS was 90.7% and 68% (p = 0.006), respectively. Thus, the response of sTK1 at the first cycle of chemotherapy could be used both as an early biomarker for the guidance of chemotherapy and for the study of inherent tumor chemo-sensitivity, which could predict long-term outcome prior to therapy.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 13215442
2072-6694
العلاقة: https://www.mdpi.com/2072-6694/13/21/5442Test; https://doaj.org/toc/2072-6694Test
DOI: 10.3390/cancers13215442
الوصول الحر: https://doaj.org/article/43f23180dbdf4735be547d759721b756Test
رقم الانضمام: edsdoj.43f23180dbdf4735be547d759721b756
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:13215442
20726694
DOI:10.3390/cancers13215442